TransMedics (TMDX) Operating Expenses (2018 - 2026)

TransMedics' Operating Expenses history runs 9 years deep, the most recent figure standing at $87.9 million for Q1 2026.

• On a quarterly basis, Operating Expenses rose 44.55% year-over-year to $87.9 million in Q1 2026; TTM through Mar 2026 was $281.3 million, a 18.28% increase from a year earlier, with the FY2025 full-year figure at $254.2 million, up 13.2% from the prior year.
• Operating Expenses grew to $87.9 million in Q1 2026 per TMDX's latest filing, from $72.1 million in the prior quarter.
• Across five years, Operating Expenses topped out at $87.9 million in Q1 2026 and bottomed at $21.5 million in Q1 2022.
• The 5-year median for Operating Expenses is $56.8 million (2024), against an average of $49.8 million.
• Across the five-year window, Operating Expenses soared 191.63% in 2023 and slipped 17.5% in 2024, its largest moves.
• Year by year, Operating Expenses stood at $27.5 million in 2022, then soared by 64.91% to $45.3 million in 2023, then jumped by 39.82% to $63.4 million in 2024, then grew by 13.84% to $72.1 million in 2025, then grew by 21.79% to $87.9 million in 2026.
• Per Business Quant, the three latest TMDX Operating Expenses figures stand at $87.9 million (Q1 2026), $72.1 million (Q4 2025), and $61.3 million (Q3 2025).